203 related articles for article (PubMed ID: 38340723)
1. Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma.
Pulliam T; Jani S; Jing L; Ryu H; Jojic A; Shasha C; Zhang J; Kulikauskas R; Church C; Garnett-Benson C; Gooley T; Chapuis A; Paulson K; Smith KN; Pardoll DM; Newell EW; Koelle DM; Topalian SL; Nghiem P
Cell Rep Med; 2024 Feb; 5(2):101412. PubMed ID: 38340723
[TBL] [Abstract][Full Text] [Related]
2. Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.
Afanasiev OK; Yelistratova L; Miller N; Nagase K; Paulson K; Iyer JG; Ibrani D; Koelle DM; Nghiem P
Clin Cancer Res; 2013 Oct; 19(19):5351-60. PubMed ID: 23922299
[TBL] [Abstract][Full Text] [Related]
3. Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy.
Miller NJ; Church CD; Fling SP; Kulikauskas R; Ramchurren N; Shinohara MM; Kluger HM; Bhatia S; Lundgren L; Cheever MA; Topalian SL; Nghiem P
J Immunother Cancer; 2018 Nov; 6(1):131. PubMed ID: 30482247
[TBL] [Abstract][Full Text] [Related]
4. Merkel cell polyomavirus-specific and CD39
Ryu H; Bi TM; Pulliam TH; Sarkar K; Church CD; Kumar N; Mayer-Blackwell K; Jani S; Ramchurren N; Hansen UK; Hadrup SR; Fling SP; Koelle DM; Nghiem P; Newell EW
Cell Rep Med; 2024 Feb; 5(2):101390. PubMed ID: 38340724
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
Iyer JG; Afanasiev OK; McClurkan C; Paulson K; Nagase K; Jing L; Marshak JO; Dong L; Carter J; Lai I; Farrar E; Byrd D; Galloway D; Yee C; Koelle DM; Nghiem P
Clin Cancer Res; 2011 Nov; 17(21):6671-80. PubMed ID: 21908576
[TBL] [Abstract][Full Text] [Related]
6. Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma.
Feldmeyer L; Hudgens CW; Ray-Lyons G; Nagarajan P; Aung PP; Curry JL; Torres-Cabala CA; Mino B; Rodriguez-Canales J; Reuben A; Chen PL; Ko JS; Billings SD; Bassett RL; Wistuba II; Cooper ZA; Prieto VG; Wargo JA; Tetzlaff MT
Clin Cancer Res; 2016 Nov; 22(22):5553-5563. PubMed ID: 27166398
[TBL] [Abstract][Full Text] [Related]
7. Insights into anti-tumor immunity
Jani S; Church CD; Nghiem P
Front Immunol; 2023; 14():1172913. PubMed ID: 37287968
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma.
Church C; Pulliam T; Longino N; Park SY; Smythe KS; Makarov V; Riaz N; Jing L; Amezquita R; Campbell JS; Gottardo R; Pierce RH; Choi J; Chan TA; Koelle DM; Nghiem P
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36252564
[TBL] [Abstract][Full Text] [Related]
9. Human CD4
Longino NV; Yang J; Iyer JG; Ibrani D; Chow IT; Laing KJ; Campbell VL; Paulson KG; Kulikauskas RM; Church CD; James EA; Nghiem P; Kwok WW; Koelle DM
Cancer Immunol Res; 2019 Oct; 7(10):1727-1739. PubMed ID: 31405946
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival.
Miller NJ; Church CD; Dong L; Crispin D; Fitzgibbon MP; Lachance K; Jing L; Shinohara M; Gavvovidis I; Willimsky G; McIntosh M; Blankenstein T; Koelle DM; Nghiem P
Cancer Immunol Res; 2017 Feb; 5(2):137-147. PubMed ID: 28093446
[TBL] [Abstract][Full Text] [Related]
11. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
[TBL] [Abstract][Full Text] [Related]
12. PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
Nghiem PT; Bhatia S; Lipson EJ; Kudchadkar RR; Miller NJ; Annamalai L; Berry S; Chartash EK; Daud A; Fling SP; Friedlander PA; Kluger HM; Kohrt HE; Lundgren L; Margolin K; Mitchell A; Olencki T; Pardoll DM; Reddy SA; Shantha EM; Sharfman WH; Sharon E; Shemanski LR; Shinohara MM; Sunshine JC; Taube JM; Thompson JA; Townson SM; Yearley JH; Topalian SL; Cheever MA
N Engl J Med; 2016 Jun; 374(26):2542-52. PubMed ID: 27093365
[TBL] [Abstract][Full Text] [Related]
13. Merkel cell polyomavirus and non-Merkel cell carcinomas: guilty or circumstantial evidence?
Csoboz B; Rasheed K; Sveinbjørnsson B; Moens U
APMIS; 2020 Feb; 128(2):104-120. PubMed ID: 31990105
[TBL] [Abstract][Full Text] [Related]
14. Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8
Jing L; Ott M; Church CD; Kulikauskas RM; Ibrani D; Iyer JG; Afanasiev OK; Colunga A; Cook MM; Xie H; Greninger AL; Paulson KG; Chapuis AG; Bhatia S; Nghiem P; Koelle DM
Cancer Immunol Res; 2020 May; 8(5):648-659. PubMed ID: 32179557
[TBL] [Abstract][Full Text] [Related]
15. T antigen-specific CD8+ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinoma.
Hansen UK; Church CD; Carnaz Simões AM; Frej MS; Bentzen AK; Tvingsholm SA; Becker JC; Fling SP; Ramchurren N; Topalian SL; Nghiem PT; Hadrup SR
J Clin Invest; 2024 Jan; 134(8):. PubMed ID: 38618958
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes.
Kumar S; Xie H; Shi H; Gao J; Juhlin CC; Björnhagen V; Höög A; Lee L; Larsson C; Lui WO
Int J Cancer; 2020 Mar; 146(6):1652-1666. PubMed ID: 31180579
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial.
Topalian SL; Bhatia S; Amin A; Kudchadkar RR; Sharfman WH; Lebbé C; Delord JP; Dunn LA; Shinohara MM; Kulikauskas R; Chung CH; Martens UM; Ferris RL; Stein JE; Engle EL; Devriese LA; Lao CD; Gu J; Li B; Chen T; Barrows A; Horvath A; Taube JM; Nghiem P
J Clin Oncol; 2020 Aug; 38(22):2476-2487. PubMed ID: 32324435
[TBL] [Abstract][Full Text] [Related]
18. Lower expression of CADM1 and higher expression of MAL in Merkel cell carcinomas are associated with Merkel cell polyomavirus infection and better prognosis.
Iwasaki T; Matsushita M; Nonaka D; Nagata K; Kato M; Kuwamoto S; Murakami I; Hayashi K
Hum Pathol; 2016 Feb; 48():1-8. PubMed ID: 26772392
[TBL] [Abstract][Full Text] [Related]
19. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.
Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
Clin Cancer Res; 2011 Jul; 17(14):4806-13. PubMed ID: 21642382
[TBL] [Abstract][Full Text] [Related]
20. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.
Lyngaa R; Pedersen NW; Schrama D; Thrue CA; Ibrani D; Met O; Thor Straten P; Nghiem P; Becker JC; Hadrup SR
Clin Cancer Res; 2014 Apr; 20(7):1768-78. PubMed ID: 24526738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
